EVOFEM BIOSCIENCES INC's ticker is EVFM and the CUSIP is 30048L104. A total of 108 filers reported holding EVOFEM BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,000 | -52.9% | 26,118 | -42.4% | 0.00% | – |
| Q4 2021 | $17,000 | -67.3% | 45,367 | -35.7% | 0.00% | – |
| Q3 2021 | $52,000 | -49.5% | 70,540 | -22.7% | 0.00% | – |
| Q2 2021 | $103,000 | +58.5% | 91,267 | +145.4% | 0.00% | – |
| Q1 2021 | $65,000 | -56.4% | 37,198 | -40.0% | 0.00% | – |
| Q4 2020 | $149,000 | +39.3% | 61,948 | +36.4% | 0.00% | – |
| Q3 2020 | $107,000 | – | 45,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 1,100,000 | $812,000 | 0.27% |
| Westside Investment Management, Inc. | 10,000 | $7,230,000 | 0.02% |
| Baker Brothers Advisors | 2,697,110 | $1,992,000 | 0.01% |
| Bedel Financial Consulting, Inc. | 22,500 | $17,000 | 0.01% |
| Congress Park Capital LLC | 14,500 | $11,000 | 0.01% |
| Callan Capital, LLC | 50,000 | $37,000 | 0.01% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1,079,860 | $798,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 60,381 | $45,000 | 0.01% |
| Platform Technology Partners | 13,000 | $10,000 | 0.01% |
| JB CAPITAL PARTNERS LP | 23,184 | $17,000 | 0.00% |